News

Please find below news from ODI Pharma AB. More stock relevant news can be found in the section "Stock Information" on the "INVESTORS" site.

Suche

ODI Pharma

25. Feb.
4 Min.

Correction: ODI Pharma AB: Publication of half-year report 2021

Correction: ODI Pharma hereby discloses a revised half-year report for the period July – December 2021. In the previous report, the cost...

0 Kommentare

ODI Pharma

24. Feb.
4 Min.

ODI Pharma AB: Publication of half-year report 2021

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2021. The report is available...

0 Kommentare

ODI Pharma

9. Juli 2021
2 Min.

ODI Pharma AB: Flagging notification

ODI Pharma AB (“ODI Pharma”) has been informed that Mr. Niclas Kappelin has acquired 20’000 shares in ODI Pharma and exceeded the...

0 Kommentare

ODI Pharma

21. Apr. 2021
3 Min.

ODI Pharma: Update on progress in “Project Poland” and “Project Skin”

In January 2021 and February 2021, ODI Pharma AB (“ODI” or the “Company”) announced the decision to expand its current business with...

0 Kommentare

ODI Pharma

22. Feb. 2021
2 Min.

ODI Pharma achieves milestone towards market entry in Poland

ODI Pharma AB (“ODI” or the “Company”) announces that its subsidiary ODI Pharma Polska Sp. z o.o. has finalized documentation and filed...

0 Kommentare

ODI Pharma

14. Jan. 2021
2 Min.

ODI Pharma proceeds with its plans and launches Project Skin

ODI Pharma AB (“ODI” or “the Company”) announces that the Board of Directors has decided to expand ODI’s current business with...

0 Kommentare

ODI Pharma

2. Nov. 2020
6 Min.

ODI PHARMA AB AND APHRIA INC. EXECUTE SUPPLY AGREEMENT

Stockholm, Sweden and Leamington, Ontario – November 2nd, 2020 – ODI Pharma AB (“ODI”, ISIN SE0013409760) today announced that, despite...

0 Kommentare

ODI Pharma

27. Aug. 2020
3 Min.

ODI Pharma AB: Publication of year-end report

ODI Pharma AB (“ODI” or “the Company”) hereby publishes its year-end report for the period July 2019 – June 2020. The report is available...

0 Kommentare

ODI Pharma

7. Apr. 2020
2 Min.

ODI Pharma AB: Status update in connection to COVID-19

ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Board of Directors does not see any impact on the Company’s mid- and...

0 Kommentare

ODI Pharma

27. Feb. 2020
3 Min.

ODI Pharma AB: Publication of half-yearly report 2019

ODI Pharma AB (“ODI” or “the Company”) hereby publishes its half-yearly report for the period October – December 2019. The report is...

0 Kommentare

ODI Pharma

20. Jan. 2020
2 Min.

First registration of ODI Pharma’s new share issue completed

Stockholm, 20.01.2020. ODI Pharma AB's ("ODI Pharma" or "Company") recently completed new share issue was significantly oversubscribed...

0 Kommentare

ODI Pharma

3. Jan. 2020
3 Min.

ODI Pharma’s new share issue prior to listing significantly oversubscribed

The subscription period in ODI Pharma AB's ("ODI Pharma" or "Company") new share issue prior to listing on Spotlight Stock Market was...

0 Kommentare

ODI Pharma

16. Dez. 2019
4 Min.

ODI Pharma has been approved for listing on Spotlight Stock Market, subscription period starts today

ODI Pharma AB (“ODI Pharma” or “the Company”), a medical cannabis finished product producer, today announces that the Company has been...

0 Kommentare